nanoComposix has specialized in the design, development, and scaled manufacturing of nanomaterials for therapeutic, diagnostic, energy, and optical applications for over 20 years. From feasibility to clinical or commercial production, we partner with companies and researchers to translate nanoparticle-enabled technologies into viable products. Our platform includes a broad portfolio of monodisperse, unagglomerated metal, metal oxide, and silica nanoparticles, alongside fully customizable solutions and CDMO services. Whether optimizing drug delivery systems, enhancing assay sensitivity, or solving optical engineering challenges, we provide the deep materials expertise needed to move confidently from R&D toward commercialization. Every batch is supported by detailed characterization data to ensure quality, reproducibility, and performance at scale.
All products are made at our facility in San Diego, California.
nanoComposix is a Fortis Life Sciences® company.
Manufacturing Certifications, Registrations, and Licenses
- ISO 13485:2016 Certificate
- FDA Medical Device Establishment Registration
- State of California Medical Device Manufacturing License
- FDA Drug Establishment Registration
- State of California Drug Manufacturing License
A Letter from Our Founder, Dr. Steve Oldenburg:
The motivation for starting nanoComposix was the frustration I had experienced as a scientist when trying to acquire high quality nanomaterials. Every time I ordered a product from a nanomaterial or chemical company I would spend many hours performing characterization only to realize that the shape, size distribution, agglomeration state, or chemical purity was not what I was expecting. I would be forced to discard the material and try another vendor. This was a time-consuming and completely unnecessary impediment to the development of technologies and products that leverage the new and exciting properties of nanomaterials.
At nanoComposix, we provide extensive characterization data with each product that we sell. Additionally, our diverse team of scientists can provide solutions to the integration problems that are a main challenge for leveraging novel nanoscale properties into commercial products. It is my hope that with improved access to highly characterized nanomaterials, researchers will be able to accelerate the pace of nanomaterials research and products that harness the potential of nanotechnology.
Steve Oldenburg
Founder, nanoComposix